![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
The use of immunotherapy in HCC – In depth subgroup analyses and challenges (COR2ED The Heart of Medical Education) View |
![]() |
Advanced HCC: Case Discussion on Immunotherapy (HMP Education) View |
![]() |
Immunotherapy in HCC (OncLive) View |
![]() |
Overview of 2nd line treatment options in advanced HCC (COR2ED The Heart of Medical Education) View |
![]() |
HIMALAYA: tremelimumab + durvalumab in unresectable HCC (VJOncology) View |
![]() |
Part 5 - Immunotherapy in HCC - Dr. Sumit Goyal, Delhi (MICE IDEAS) View |
![]() |
Case Discussion: Immunotherapy for Advanced HCC (HMP Education) View |
![]() |
Hepatocellular Carcinoma: Future Role of Immunotherapy (OncLive) View |
![]() |
Debate: Optimal first-line therapy in unresectable HCC - MKI followed by immunotherapy (HMP Education) View |
![]() |
First-line regorafenib 80mg/day with pembrolizumab in advanced HCC (VJOncology) View |